Académique Documents
Professionnel Documents
Culture Documents
THÉMATIQUE À TAPER
(HPV)
HPV et cancers :
mécanismes de l’oncogenèse
Christiane Mougina,*, Magali Nicoliera, Anne-Zélie Decrion-Barthoda
RÉSUMÉ
D génotypes
Des é t spécifiques
é ifi de
d papillomavirus
ill i humains
h i dits
dit « à haut
h t risque
i » SUMMARY
sont responsables du cancer du col utérin, le deuxième cancer au monde HPV and cancer : mechanisms of oncogenesis
chez la femme. La transformation cellulaire et le maintien du phénotype Specific genotypes of high risk human
malin sont liés en particulier à l’expression de deux protéines virales E6 papillomaviruses are responsible of cervical
et E7. Ces protéines interfèrent avec de nombreuses protéines cellulaires cancer, the second tumor in women worldwide.
impliquées dans la régulation du cycle cellulaire, le contrôle de l’apoptose, Cellular transformation and maintenance of the
la réparation de l’ADN, la formation du fuseau mitotique, l’adhérence malignant phenotype are mainly linked to the
intercellulaire et à la matrice extracellulaire, la motilité cellulaire et les voies expression of the viral E6 and E7 proteins. These
de transduction des signaux mitogènes. oncoproteins target many cellular proteins involved
in cell cycle regulation, apoptosis control, DNA
Papillomavirus – HPV – E5, E6, E7 – oncogenèse – cancer. repair, spindle formation, intercellular and cell-
extracellular matrix adhesion, cell motility and
mitogenic signal transduction pathways.
Références [9] Calaluce R., Bearss D.J., Barrera J., Zhao Y., Han H., Beck S.K.,
McDaniel K., Nagle R.B., Laminin-5 beta3A expression in LNCaP human
[1] Alvarez-Salas L.M., Cullinan A.E., Siwkowski A., Hampel A., DiPaolo prostate carcinoma cells increases cell migration and tumorigenicity,
J.A., Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes Neoplasia 6 (5) (2004) 468-479.
by hairpin ribozymes, Proc. Natl. Acad. Sci. USA 95 (3) (1998) 1189-
[10] Calin G.A., Croce C.M., MicroRNA-cancer connection: the begin-
1194.
ning of a new tale, Cancer Res. 66 (15) (2006) 7390-7394.
[2] Ashrafi G.H., Haghshenas M., Marchetti B., Campo M.S., E5 protein
[11] Cheng W.F., Chen C.A., Lee C.N., Wei L.H., Hsieh F.J., Hsieh C.Y.,
of human papillomavirus 16 downregulates HLA class I and interacts
Vascular endothelial growth factor and prognosis of cervical carcinoma,
with the heavy chain via its first hydrophobic domain, Int. J. Cancer 119
Obstet. Gynecol. 96 (5 Pt 1) (2000) 721-726.
(9) (2006) 2105-2112.
[12] Clere N., Bermont L., Fauconnet S., Lascombe I., Saunier M.,
[3] Aubin F., Pretet J.L., Jacquard A.C., Saunier M., Carcopino X., Jaroud
Vettoretti L., Plissonnier M.L., Mougin C., The human papillomavirus
F., Pradat P., Soubeyrand B., Leocmach Y., Mougin C., Riethmuller D.,
type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121
Human papillomavirus genotype distribution in external acuminata
(VEGF121) transcription from the promoter through a p53-independent
condylomata. A large French national study (EDITH IV), Clin. Infect. Dis.
(sous presse) (2008). mechanism, Exp. Cell. Res. 313 (15) (2007) 3239-3250.
[4] Barbosa M.S., Edmonds C., Fisher C., Schiller J.T., Lowy D.R., Vousden [13] Davidson E.J., Boswell C.M., Sehr P., Pawlita M., Tomlinson A.E.,
K.H., The region of the HPV E7 oncoprotein homologous to adenovirus McVey R.J., Dobson J., Roberts J.S., Hickling J., Kitchener H.C., Stern
E1a and SV40 large T antigen contains separate domains for Rb binding P.L., Immunological and clinical responses in women with vulval intraepi-
and casein kinase II phosphorylation, EMBO J. 9 (1) (1990) 153-160. thelial neoplasia vaccinated with a vaccinia virus encoding human papillo-
mavirus 16/18 oncoproteins, Cancer Res. 63 (18) (2003) 6032-6041.
[5] Bosch F.X., Manos M.M., Muñoz N., Sherman M., Jansen A.M.,
Peto J., Schiffman M.H., Moreno V., Kurman R., Shah K.V., Prevalence [14] de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen
of human papillomavirus in cervical cancer: a worldwide perspective. H., Classification of papillomaviruses, Virology 324 (1) (2004) 17-27.
International biological study on cervical cancer (IBSCC) Study Group, [15] Disbrow G.L., Hanover J.A., Schlegel R., Endoplasmic reticulum-
J. Natl. Cancer Inst. 87 (11) (1995) 796-802. localized human papillomavirus type 16 E5 protein alters endosomal pH
[6] Bosch F.X., Munoz N., Human papillomavirus and cervical neoplasia, but not trans-Golgi pH, J. Virol. 79 (9) (2005) 5839-5846.
in: Munoz N., Bosch F.X. and Jensen O.M. (Eds), Human papillomavirus [16] Duensing S., Munger K., Human papillomaviruses and centrosome
and cervical cancer, IARC Scientific Publications, 1989, pp. 135-151. duplication errors: modeling the origins of genomic instability, Oncogene
[7] Bousarghin L., Touze A., Sizaret P.Y., Coursaget P., Fixation, inter- 21 (40) (2002) 6241-6248.
nalisation et trafic cellulaire des papillomavirus, in: Aubin F., Mougin C. [17] Filippova M., Parkhurst L., Duerksen-Hughes P.J., The human
and Pretet J.L. (Eds), Papillomavirus humains : biologie et pathologie papillomavirus 16 E6 protein binds to Fas-associated death domain
tumorale, Lavoisier, 2003, pp. 25-34. and protects cells from Fas-triggered apoptosis, J. Biol. Chem. 279 (24)
[8] Brown D.R., Schroeder J.M., Bryan J.T., Stoler M.H., Fife K.H., (2004) 25729-25744.
Detection of multiple human papillomavirus types in Condylomata acu- [18] Franco E.L., The sexually transmitted disease model for cervical can-
minata lesions from otherwise healthy and immunosuppressed patients, cer: incoherent epidemiologic findings and the role of misclassification of
J. Clin. Microbiol. 37 (10) (1999) 3316-3322. human papillomavirus infection, Epidemiology 2 (2) (1991) 98-106.